Pay in 4 interest-free payments of $6.35 Learn more
Ships within 48 hours · Estimated delivery Sep 18 - Sep 23
glp 1 candidates What's next for GLP-1 innovation: A primer on the race reshaping pharma and chronic disease care DigitalFitnessProgram AstraZeneca buys rights to Type:Paperback
AstraZeneca buys rights to GLP-1 drug from Eccogene for $185M upfront
[DOI] [PubMed] [Google Scholar] 45.Pinelli NR, Patel A, Salinitri FD
DigitalFitnessProgram
Type:Paperback
It is especially beneficial for individuals who are obese or overweight, as it can significantly reduce their risk of developing obesity-related diseases
